Skip to main content

Economics

Day 4 EULAR Report

The last day in London was exciting as both the Late-Breaking abstracts and new EULAR guidelines were presented. Guidelines presented addressed several significant unmet need areas including PMR, GCA, Takayasu’s arteritis, Vaccinations in Rheumatic patients, Imaging in spondyloarthritis and

Read Article
Our expanded #EULAR2026 coverage is made possible by support from Bristol Myers Squibb and UCB. All content is independently chosen and produced by the RheumNow faculty.

Dr. John Cush @RheumNow( View Tweet )

Which imaging test has the highest carbon footprint??? Think wisely before prescribing 🩻 #EULAR2026 @RheumNow https://t.co/36Ej8smWRd
Nelly ZIADE 🍀 @Nellziade( View Tweet )
🩺🌳When good clinical practice meets reducing environmental burden of healthcare: Rheumatologists can do a lot! Less is more ⬇️ Thank you @eular_org for planning environmental awareness sessions Looking forward to #greener congresses #EULAR2026 @RheumNow https://t.co/5FwARRi92m
Nelly ZIADE 🍀 @Nellziade( View Tweet )
Rheumatology Shortage Cliff in Australia & USA Australia is facing a deepening rheumatology manpower crisis with direct parallels to the situation in the United States. The Australian Rheumatology Association's 2025 Workforce Report warns that the nation faces a significant https://t.co/qVziLM25JR
Dr. John Cush @RheumNow( View Tweet )

Rheumatology Shortage Cliff in Australia & USA

Australia is facing a deepening rheumatology manpower crisis with direct parallels to the situation in the United States.

Read Article

Increased Polypharmacy in SLE Patients

A cross-sectional study of US adults with systemic lupus erythematosus (SLE) shows significantly increased prevalence of polypharmacy, related to age, disease outcomes and often, non-SLE common medications.

A

Read Article

Integrating D2T into T2T Practices in RA

EurekAlert!

Researchers at Semmelweis University analyzed how depression, smoking, obesity, sleep disorders, and other health problems are linked to difficult-to-treat rheumatoid arthritis (D2T-RA) and how this can inform treat-to-target (T2T) and individualized therapy.

Read Article

WSJ: Nurse Practitioner Is Now the Hottest Job in Healthcare

The Wall St. Journal has published a perspective on nurse practitioners (NP) and their very promising careers.

The U.S. healthcare system is undergoing a

Read Article
Let me give you an example of where there is no gov intervention, and the impact on brand drug pricing. When a brand manufacturer sells a drug to one of the big 3 drug distributors that control more than 90 pct of their market, those multi hundred billion dollar distributors

Mark Cuban @mcuban( View Tweet )

Quiz Talk (5.22.2026)

Dr. Jack Cush talks of birthdays, Quizzes and journal articles this week on the podcast.

Read Article

BE BOLD Week 16 data - Bimekizumab vs. Risankizumab in PsA

UCB has released the Week 16 results from BE BOLD trial that will be presented at EULAR 2026 in London on Saturday, June 6. This head-to-head trial demonstrates that at week 16, bimekizumab (BKZ) yielded superior ACR50 results compared to risankizumab (RKB) adults with active psoriatic

Read Article
Medical Economics reports only 18% MDs practiced in MD-owned settings, a new low. By Jan '26 hospitals or corporate employment rose to 550,494 & independent MDs fell to 120,900 https://t.co/l0tt3yO9kt https://t.co/pkgmHFPjE1
Dr. John Cush @RheumNow( View Tweet )

Does Exercise and Lifestyle Modification Improve RA?

Does exercise or lifestyle modifications reduce the risk of getting rheumatoid arthritis (RA) or change those with early RA? A current review and meta-analysis found no studies addressing benefit in pre-clinical RA, but found evidence that exercise improves
Read Article
“60-40-20” - Ed Keystone (rumor has it he was actually bidding on a copy of my textbook!)

Dr. John Cush @RheumNow( View Tweet )

Influential Rheumatoid Factors (5.8.2026)

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Read Article

Nurses - the calm through chaos

Gloria was the charge nurse on 3 West when a “code” was called. Action, running, and commotion ensues as the crash cart, nurses, and respiratory therapist appear at the bedside. Two residents emerge as the patient is hooked up to the monitor. While everyone assumes their position and role,

Read Article
U.S. spending on prescription drugs in 2025 jumped 13% to $915 billion=projected to surpass $1 trillion in 2026, according to ASHP/USA today. One major reason– the popularity of the weight-loss and diabetes drugs tirzepatide and semaglutide. https://t.co/EQ9yFCCdBp https://t.co/cig1jNp6NF
Dr. John Cush @RheumNow( View Tweet )
Rheumatology Salaries 2025 Medscape has published its annual Physician Compensation report with physican salaries up roughly 3% and eight specialties earning more than $500,000 per annum. https://t.co/DNe42EsxRW https://t.co/aegcNm8Pla
Dr. John Cush @RheumNow( View Tweet )

Follow the Money (4.23.2026)

Dr. Jack Cush follows the money and all the news that fits the Rheumatology Gab for this past week. 

Read Article
Rheumatology Salaries 2025 Medscape has published its annual Physician Compensation report with physican salaries up roughly 3% and eight specialties earning more than $500,000 per annum. https://t.co/UKc2l4FBQZ https://t.co/Kqzbl6pGWh
Dr. John Cush @RheumNow( View Tweet )

Twofold Mortality in SLE

Despite declining incidence of lupus, mortality for SLE was twice that of controls in this large incident cohort study.

Ethnicity is a strong predictor of incidence and outcomes in systemic lupus erythematosus (SLE) patients. This population study used the UK Clinical Practice

Read Article

Rheumatology Salaries 2025

Medscape has published its annual Physician Compensation report with physican salaries up roughly 3% and eight specialties earning more than $500,000 per annum. 

Read Article
IN 2025 DTC TV ad spending by top 10 incr to $2.67 billion (up from $2.1 B). Rheum Drugs in top 3: 1. Skyrizi $440 million 2. Tremfya $431 M 3. Rinvoq $376 M https://t.co/EsWgUqUy9Z https://t.co/zVHdVA2puZ
Dr. John Cush @RheumNow( View Tweet )
ACR Backs the Provider Reimbursement Stability Act The ACR thanked lawmakers in the U.S. House of Representatives for introducing the bipartisan Provider Reimbursement Stability Act of 2025 (H.R. 8163), legislation designed to stabilize Medicare payments for physicians and https://t.co/15xU3DGD34
Dr. John Cush @RheumNow( View Tweet )
×